EFFICACY AND SAFETY OF RIFAXIMIN FOR PATIENTS WITH CHRONIC INTESTINAL PSEUDO-OBSTRUCTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A TRIAL

Takaomi Kessoku  1     Hidenori Ohkubo  1     TOMOKI OGATA  1     Tsumugi Jono  1     Kosuke Tanaka  1     Kota Takahashi  1     Atsushi Yamamoto  1     Tomohiro Takatsu  1     Tsutomu Yoshihara  1     Noboru Misawa  1     Keiichi Ashikari  1     Akiko Fuyuki  1     Takuma Higurashi  1     Toshihiro Misumi  2     Satoru Shinoda  2     Yukako Horikoshi  3     Emi Misugi  3     Hiroe Asuke  4     Katsuhiko Miyazawa  4     Ikuya Sato  4     Atsushi Nakajima  4    
1 Yokohama City University Graduate School of Medicine, Yokohama, Japan
2 Yokohama City University School of Medicine, Yokohama, Japan
3 Yokohama City University Hospital, Yokohama, Japan
4 ASKA Pharmaceutical Co., Ltd., Tokyo, Japan

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing